Join our growing community to challenge mainstream media bias and fix the news
Gilead trades that made millions on COVID-19 drug news raise eyebrows

Gilead trades that made millions on COVID-19 drug news raise eyebrows

Trading in shares of Gilead Sciences ahead of news about a possible Covid-19 treatment may draw regulatory scrutiny, Reuters reported. The US pharmaceutical company announced promising results in early stages of its trials on 17 April, sending its share price up 10%. But the previous day, when shares hovered around $75, four large blocks of options were reportedly purchased for about $1.5m each.

KCooper
KCooper
Top in Business